Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP251595.RAqw6Ospt4T7bIcxrKHQu2PTqbYtqrVZgoynx7r5bl4A8130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251595.RAqw6Ospt4T7bIcxrKHQu2PTqbYtqrVZgoynx7r5bl4A8130_provenance.
• NP598100.RADl5rl0AlDgayQDEEGBnrocRalQo7C8IN9ma9QFnk4dU130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598100.RADl5rl0AlDgayQDEEGBnrocRalQo7C8IN9ma9QFnk4dU130_provenance.
• NP598102.RABJdO9wchNqABCIpVnyn5py3ZYwP5P0aO2rwfoGIOR8s130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598102.RABJdO9wchNqABCIpVnyn5py3ZYwP5P0aO2rwfoGIOR8s130_provenance.
• NP598103.RAaSMM1bjHRn5Tj9lIaLrc-DLgfuiSCG0nPXIMhood3_M130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598103.RAaSMM1bjHRn5Tj9lIaLrc-DLgfuiSCG0nPXIMhood3_M130_provenance.
• NP892941.RAmA15LJ0QtXgrN3CLoGmUr4HSlBkY4GnqJvzsCw1cY9s130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892941.RAmA15LJ0QtXgrN3CLoGmUr4HSlBkY4GnqJvzsCw1cY9s130_provenance.
• NP598101.RAngglcYgN8v7-kCl-qYCd9vM6re-x0RyfRuGslW7HUJc130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598101.RAngglcYgN8v7-kCl-qYCd9vM6re-x0RyfRuGslW7HUJc130_provenance.
• NP436092.RAJrPyIInM9vgonAxftacs4rG2kaBBrDWbce0NPAGiN6c130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436092.RAJrPyIInM9vgonAxftacs4rG2kaBBrDWbce0NPAGiN6c130_provenance.
• NP980638.RA1JsRZwyi8FdjPoiggzbaBS9_APJn8l9xsOUNbkQlgSA130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980638.RA1JsRZwyi8FdjPoiggzbaBS9_APJn8l9xsOUNbkQlgSA130_provenance.
• NP598099.RA5N_cu0dYNrd1pgsS9nzNp9RzVWuHhcrxa1uBA7zijVQ130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598099.RA5N_cu0dYNrd1pgsS9nzNp9RzVWuHhcrxa1uBA7zijVQ130_provenance.
• NP598104.RA2tLxg72M5nkzOYV8i5lizjXiF_fLTOaUZ-cUeoNenD0130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598104.RA2tLxg72M5nkzOYV8i5lizjXiF_fLTOaUZ-cUeoNenD0130_provenance.
• NP878420.RA1DLo0xMD5uT9y_tbY5Q7cgsb0CemXDgNnvVw4xXop8s130_assertion description "[GRP appears to rescue NSCLC cells exposed to gefitinib through release of amphiregulin and activation of the Akt pathway, suggesting GRPR and/or EGFR autocrine pathways in NSCLC cells may modulate therapeutic response to EGFR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878420.RA1DLo0xMD5uT9y_tbY5Q7cgsb0CemXDgNnvVw4xXop8s130_provenance.